Top Markets
Coin of the day
Qlife Holding AB (publ) Qlife Holding AB (publ)

Qlife Holding AB (publ)

QLIFE
Rank in Stocks #36577
Operating as a medical technology firm, Qlife Holding AB (publ) specializes in... Operating as a medical technology firm, Qlife Holding AB (publ) specializes in the production and distribution of in-vitro diagnostic instruments and their associated chemical reagents. Their flagship offering is the Egoo.Health Platform, a comprehensive system comprising a measuring device, single-use test capsules, and integrated software. This innovative platform facilitates the detection of various biomarkers or viral agents, with each capsule tailored for a distinct diagnostic purpose. The range of supported biomarkers encompasses C-reactive protein for home-based monitoring, Phenylalanine (PHE) vital for managing Phenylketonuria (PKU) in patients, and a multiplex test designed to identify Sars-CoV-2 and Influenza, aiding in the detection of viral and bacterial infections. Established in 2019, Qlife's operations are headquartered in Helsingborg, Sweden.
Share Price
$0.20529272
Last synced: 2026-08-14
Market Cap
$2.54M
Change (1 day)
0.11%
Change (1 year)
-49.29%
Country
SE
Trade Qlife Holding AB (publ) (QLIFE)

Category

Earnings for Qlife Holding AB (publ) (QLIFE)
Earnings in 2026 TTM: 0
According to Qlife Holding AB (publ) latest financial reports the company's current earnings are 0. In 2026 the company made an earning of 0, equal to its 2026 earnings that were of 0. The earnings displayed on this page are the earnings before interest and taxes or simply EBIT.
Earnings history for Qlife Holding AB (publ) from 2026 to 2026
Earnings at the end of each year
Year Earnings Change
Not enough data for the provided dates.
Earnings for similar companies or competitors
Company Earnings Earnings Difference Country
$7.51B -
US
$5.15B -
US
$5.56B -
IE
$3.86B -
US
$1.42B -
US